ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article

Abraham, William T.; Chin, Marshall H.; Feldman, Arthur M.; Francis, Gary S.; Ganiats, Théodore G.; Jessup, Mariell; Konstam, Marvin A.; Mancini, Donna; Michl, Keith; Oates, John A.; Rahko, Peter S.; Silver, Marc A.; Stevenson, Lynne Warner; Yancy, Clyde W.; Antman, Elliott M.; Smith, Sidney C.; Adams, Cynthia D.; Anderson, Jeffrey L.; Faxon, David P.; Fuster, Valentı́n; Halperin, Jonathan L.; Hiratzka, Loren F.; Hunt, Sharon A.; Jacobs, Alice K.; Nishimura, Rick A.; Ornato, Joseph P.; Page, Richard L.; Riegel, Bárbara

doi:10.1161/circulationaha.105.167587

Cited by 370 publications

(41 citation statements)

References 204 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the US, African Americans have a higher prevalence of HF than persons of other ethnicities. They also present with symptoms of HF at younger ages, which are less likely to be due to coronary artery disease than in Caucasians (33)(34)(35). Recently published data from the Coronary Artery Risk Development in Young Adults (CARDIA) study (36) indicated that one in 100 African American men and women develop HF at an average age of 39 years, which is 20 times the rate in Caucasians.…”

Section: The Black Populationmentioning

confidence: 99%

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

Howlett¹,

McKelvie²,

Costigan³

et al. 2010

Canadian Journal of Cardiology

100

View full text Add to dashboard Cite

Section: The Black Populationmentioning

confidence: 99%

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

Howlett¹,

McKelvie²,

Costigan³

et al. 2010

Canadian Journal of Cardiology

100

View full text Add to dashboard Cite

“…In the case presented, the patient was nonadherent to the cardiovascular medications that he was prescribed following CABG surgery. Because depression is associated with medication nonadherence and because preventive medications decrease morbidity and mortality in patients with cardiovascular disease, [34][35][36] it is possible that depression and its associated medication nonadherence contributed to this patient's MI. Medication nonadherence may also be a marker of other unhealthy behaviors that increase risk of cardiac events in depressed patients.…”

Section: How Might Depression Lead To Cardiac Events?mentioning

confidence: 99%

Depression and Cardiovascular Disease

Whooley¹

2006

JAMA

219

163

View full text Add to dashboard Cite

Major depressive disorder is a risk factor for the development of incident coronary heart disease events in healthy patients and for adverse cardiovascular outcomes in patients with established heart disease. Depression is present in 1 of 5 outpatients with coronary heart disease and in 1 of 3 outpatients with congestive heart failure, yet the majority of cases are not recognized or appropriately treated. It is not known whether treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. This article evaluates the importance of major depression in patients with cardiovascular disease, and provides practical guidance for identifying and treating this disorder. CASE PRESENTATIONA 58-year-old man with a history of coronary heart disease (CHD), type 2 diabetes mellitus, hypertension, smoking, and alcohol dependence presented for routine medical care. He had initially sought medical attention for exertional angina 5 years previously, at which time he underwent exercise treadmill testing with thallium that was positive for reversible perfusion defects in the anterior, septal, and inferior walls. Subsequent coronary angiography revealed diffuse heavy calcifications in the left anterior descending artery with a moderate lesion prior to the first diagonal. Several major septal perforators had significant lesions at their origins. In the dominant right coronary artery, there were diffuse calcifications but no significant lesions. The left circumflex and large ramus intermedius were free of discrete lesions. Left ventricular function was normal.The patient underwent single-vessel (left internal mammary artery to left anterior descending artery) coronary artery bypass grafting (CABG) surgery. He was prescribed atenolol 100 mg/ d, lisinopril 40 mg/d, lovastatin 80 mg/d, aspirin 325 mg/d, metformin 850 mg 3 times a day, and glipizide 10 mg 2 times a day. Despite being nonadherent to his prescribed medications, he remained stable for 5 years, but then one day, while doing household chores, he suddenly developed chest pressure, shortness of breath, and diaphoresis that lasted 12 hours. On admission to the hospital his troponin I was elevated and peaked at 0.7 ng/mL (normal, <0.05 ng/mL), consistent with a myocardial infarction (MI). His electrocardiogram had not changed.

show abstract

“…It is a complex process that may result from any structural or functional cardiac disorder that weakens the ability of the ventricles to fill or eject blood [5,14]. It is the result of complex interactions among molecular, endocrine, and biodynamic systems.…”

Section: Risk Factors Of Heart Failurementioning

confidence: 99%

Therapeutic heat and cold in cardiac rehabilitation

Habash¹,

Habash²,

El-Hage³

2017

Phys Ther Rehabil

View full text Add to dashboard Cite

Background: Heart failure (HF) is an emerging epidemic that affects both sexes and all races. It is a complex clinical disease with symptoms caused from any structural or functional cardiac disorder, resulting in reduced longevity. HF is a weakening process that is difficult to treat and it exists in various conditions in which therapy needs to be customized. HF has reached epidemic scopes, mainly among the elderly, in whom it might be a reason for hospitalization. Common types of therapy for HF cases focus on pharmaceuticals and medical instrumentation. However, new approaches of patient-centered care that are based on complementary management strategies, improving quality of life without causing an economic worry or health side effects, are needed to decrease hospitalizations. Purpose: Epidemiology, public health, risk factors, HF management, and several therapeutic heat and cold modalities have been investigated and discussed. Results: Thermotherapy has a scientific evidence-based effect on the human body and can be used for treatment and rehabilitation of the heart. Conclusion: The progress made in bioheat transfer modelling and energy delivery techniques will have an impact on the development of effective therapeutic modalities that deliver controlled heat and/or cold to the human body.

show abstract

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article

Cited by 370 publications

References 204 publications

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

Depression and Cardiovascular Disease

Therapeutic heat and cold in cardiac rehabilitation

Contact Info

Product

Resources

About